Sampling for pharmaceuticals and personal care products (PPCPs) and illicit drugs in wastewater systems: Are your conclusions valid? A critical review

Ort, Christoph, Lawrence, Michael Glen, Rieckermann, Jorg and Joss, Adriano (2010) Sampling for pharmaceuticals and personal care products (PPCPs) and illicit drugs in wastewater systems: Are your conclusions valid? A critical review. Environmental Science & Technology, 44 16: 6024-6035. doi:10.1021/es100779n


Author Ort, Christoph
Lawrence, Michael Glen
Rieckermann, Jorg
Joss, Adriano
Title Sampling for pharmaceuticals and personal care products (PPCPs) and illicit drugs in wastewater systems: Are your conclusions valid? A critical review
Journal name Environmental Science & Technology   Check publisher's open access policy
ISSN 0013-936X
1520-5851
Publication date 2010-07-26
Year available 2010
Sub-type Article (original research)
DOI 10.1021/es100779n
Volume 44
Issue 16
Start page 6024
End page 6035
Total pages 12
Editor Jerald Schnoor
Place of publication Washington, DC, United States
Publisher American Chemical Society
Collection year 2011
Language eng
Abstract The analysis of 87 peer-reviewed journal articles reveals that sampling for pharmaceuticals and personal care products (PPCPs) and illicit drugs in sewers and sewage treatment plant influents is mostly carried out according to existing tradition or standard laboratory protocols. Less than 5% of all studies explicitly consider internationally acknowledged guidelines or methods for the experimental design of monitoring campaigns. In the absence of a proper analysis of the system under investigation, the importance of short-term pollutant variations was typically not addressed. Therefore, due to relatively long sampling intervals, potentially inadequate sampling modes, or insufficient documentation, it remains unclear for the majority of reviewed studies whether observed variations can be attributed to "real" variations or if they simply reflect sampling artifacts. Based on results from previous and current work, the present paper demonstrates that sampling errors can lead to overinterpretation of measured data and ultimately, wrong conclusions. Depending on catchment size, sewer type, sampling setup, substance of interest, and accuracy of analytical method, avoidable sampling artifacts can range from "not significant" to "100% or more" for different compounds even within the same study. However, in most situations sampling errors can be reduced greatly, and sampling biases can be eliminated completely, by choosing an appropriate sampling mode and frequency. This is crucial, because proper sampling will help to maximize the value of measured data for the experimental assessment of the fate of PPCPs as well as for the formulation and validation of mathematical models. The trend from reporting presence or absence of a compound in "clean" water samples toward the quantification of PPCPs in raw wastewater requires not only sophisticated analytical methods but also adapted sampling methods. With increasing accuracy of chemical analyses, inappropriate sampling increasingly represents the majorsource of inaccuracy. A condensed step-by-step Sampling Guide is proposed as a starting point for future studies. © 2010 American Chemical Society.
Keyword Sampling
Pharmaceuticals
Personal Care Products
Illicit Drug
Wastewater
Variation
STP
References 1. Daughton, C. G.; Ruhoy, I. S. Environmental footprint of pharmaceuticals: the significance of factors beyond direct excretion to sewers Environ. Toxicol. Chem. 2009, 28 ( 12) 2495– 2521[CrossRef], [PubMed], [ChemPort] 2. Joss, A.; Siegrist, H.; Ternes, T. A. Are we about to upgrade wastewater treatment for removing organic micropollutants? Water Sci. Technol. 2008, 57 ( 2) 251– 255[CrossRef], [PubMed], [ChemPort] 3. U.S. EPA. Handbook for Sampling and Sample Preservation of Water and Wastewater; 600/4-82-029; Environmental Monitoring and Support Laboratory, 1982. 4. Andersen, H.; Siegrist, H.; Halling-Sorensen, B.; Ternes, T. A. Fate of estrogens in a municipal sewage treatment plant Environ. Sci. Technol. 2003, 37 ( 18) 4021– 4026[ACS Full Text ], [PubMed], [ChemPort] 5. Baronti, C.; Curini, R.; D’Ascenzo, G.; Di Corcia, A.; Gentili, A.; Samperi, R. Monitoring natural and synthetic estrogens at activated sludge sewage treatment plants and in a receiving river water Environ. Sci. Technol. 2000, 34 ( 24) 5059– 5066[ACS Full Text ], [ChemPort] 6. Batt, A. L.; Kim, S.; Aga, D. S. Enhanced biodegradation of iopromide and trimethoprim in nitrifying activated sludge Environ. Sci. Technol. 2006, 40 ( 23) 7367– 7373[ACS Full Text ], [PubMed], [ChemPort] 7. Bendz, D.; Paxeus, N. A.; Ginn, T. R.; Loge, F. J. Occurrence and fate of pharmaceutically active compounds in the environment, a case study: Hoje River in Sweden J. Hazard. Mater. 2005, 122 ( 3) 195– 204[CrossRef], [PubMed], [ChemPort] 8. Bernhard, M.; Muller, J.; Knepper, T. R. Biodegradation of persistent polar pollutants in wastewater: Comparison of an optimized lab-scale membrane bioreactor and activated sludge treatment Water Res. 2006, 40 ( 18) 3419– 3428[CrossRef], [PubMed], [ChemPort] 9. Boillot, C.; Bazin, C.; Tissot-Guerraz, F.; Droguet, J.; Perraud, M.; Cetre, J. C.; Trepo, D.; Perrodin, Y. Daily physicochemical, microbiological and ecotoxicological fluctuations of a hospital effluent according to technical and care activities Sci. Total Environ. 2008, 403 ( 1−3) 113– 129[PubMed], [ChemPort] 10. Boleda, M. R.; Galceran, M. T.; Ventura, F. Monitoring of opiates, cannabinoids and their metabolites in wastewater, surface water and finished water in Catalonia, Spain Water Res. 2009, 43 ( 4) 1126– 1136[CrossRef], [PubMed], [ChemPort] 11. Bones, J.; Thomas, K. V.; Paull, B. Using environmental analytical data to estimate levels of community consumption of illicit drugs and abused pharmaceuticals J. Environ. Monit. 2007, 9 ( 7) 701– 707[CrossRef], [PubMed], [ChemPort] 12. Buser, H. R.; Poiger, T.; Muller, M. D. Occurrence and environmental behavior of the chiral pharmaceutical drug ibuprofen in surface waters and in wastewater Environ. Sci. Technol. 1999, 33 ( 15) 2529– 2535[ACS Full Text ], [ChemPort] 13. Carballa, M.; Omil, F.; Lema, J. M. Calculation methods to perform mass balances of micropollutants in sewage treatment plants. Application to pharmaceutical and personal care products (PPCPs) Environ. Sci. Technol. 2007, 41 ( 3) 884– 890[ACS Full Text ], [PubMed], [ChemPort] 14. Carballa, M.; Omil, F.; Lema, J. M.; Llompart, M.; Garcia, C.; Rodriguez, I.; Gomez, M.; Ternes, T. Behaviour of pharmaceuticals and personal care products in a sewage treatment plant of northwest Spain Water Sci. Technol. 2005, 52 ( 8) 29– 35[PubMed], [ChemPort] 15. Carballa, M.; Omil, F.; Lema, J. M.; Llompart, M.; Garcia-Jares, C.; Rodriguez, I.; Gomez, M.; Ternes, T. Behavior of pharmaceuticals, cosmetics and hormones in a sewage treatment plant Water Res. 2004, 38 ( 12) 2918– 2926[CrossRef], [PubMed], [ChemPort] 16. Castiglioni, S.; Bagnati, R.; Fanelli, R.; Pomati, F.; Calamari, D.; Zuccato, E. Removal of pharmaceuticals in sewage treatment plants in Italy Environ. Sci. Technol. 2006, 40 ( 1) 357– 363[ACS Full Text ], [PubMed], [ChemPort] 17. Castiglioni, S.; Zuccato, E.; Crisci, E.; Chiabrando, C.; Fanelli, R.; Bagnati, R. Identification and measurement of illicit drugs and their metabolites in urban wastewater by liquid chromatography-tandem mass spectrometry Anal. Chem. 2006, 78 ( 24) 8421– 8429[ACS Full Text ], [PubMed], [ChemPort] 18. Celiz, M. D.; Perez, S.; Barcelo, D.; Aga, D. S. Trace analysis of polar pharmaceuticals in wastewater by LC-MS-MS: comparison of membrane bioreactor and activated sludge systems J. Chromatogr. Sci. 2009, 47 ( 1) 19– 25[PubMed], [ChemPort] 19. Chiaia, A. C.; Banta-Green, C.; Field, J. Eliminating Solid Phase Extraction with Large-Volume Injection LC/MS/MS: Analysis of Illicit and Legal Drugs and Human Urine Indicators in US Wastewaters Environ. Sci. Technol. 2008, 42 ( 23) 8841– 8848[ACS Full Text ], [PubMed], [ChemPort] 20. Clara, M.; Kreuzinger, N.; Strenn, B.; Gans, O.; Kroiss, H. The solids retention time - a suitable design parameter to evaluate the capacity of wastewater treatment plants to remove micropollutants Water Res. 2005, 39 ( 1) 97– 106[CrossRef], [PubMed], [ChemPort] 21. Clara, M.; Strenn, B.; Ausserleitner, M.; Kreuzinger, N. Comparison of the behaviour of selected micropollutants in a membrane bioreactor and a conventional wastewater treatment plant Water Sci. Technol. 2004, 50 ( 5) 29– 36[PubMed], [ChemPort] 22. Clara, M.; Strenn, B.; Gans, O.; Martinez, E.; Kreuzinger, N.; Kroiss, H. Removal of selected pharmaceuticals, fragrances and endocrine disrupting compounds in a membrane bioreactor and conventional wastewater treatment plants Water Res. 2005, 39 ( 19) 4797– 4807[CrossRef], [PubMed], [ChemPort] 23. Feldmann, D. F.; Zuehlke, S.; Heberer, T. Occurrence, fate and assessment of polar metamizole (dipyrone) residues in hospital and municipal wastewater Chemosphere 2008, 71 ( 9) 1754– 1764[CrossRef], [PubMed], [ChemPort] 24. Gautam, A. K.; Kumar, S.; Sabumon, P. C. Preliminary study of physico-chemical treatment options for hospital wastewater J. Environ. Manage. 2007, 83 ( 3) 298– 306[CrossRef], [PubMed], [ChemPort] 25. Gobel, A.; McArdell, C. S.; Joss, A.; Siegrist, H.; Giger, W. Fate of sulfonamides, macrolides, and trimethoprim in different wastewater treatment technologies Sci. Total Environ. 2007, 372 ( 2−3) 361– 371[PubMed] 26. Gomez, M. J.; Bueno, M. J. M.; Lacorte, S.; Fernandez-Alba, A. R.; Aguera, A. Pilot survey monitoring pharmaceuticals and related compounds in a sewage treatment plant located on the Mediterranean coast Chemosphere 2007, 66 ( 6) 993– 1002[CrossRef], [PubMed], [ChemPort] 27. Gupta, P.; Mathur, N.; Bhatnagar, P.; Nagar, P.; Srivastava, S. Genotoxicity evaluation of hospital wastewaters Ecotoxicol. Environ. Saf. 2009, 72 ( 7) 1925– 1932[CrossRef], [PubMed], [ChemPort] 28. Hartmann, A.; Alder, A. C.; Koller, T.; Widmer, R. M. Identification of fluoroquinolone antibiotics as the main source of umuC genotoxicity in native hospital wastewater Environ. Toxicol. Chem. 1998, 17 ( 3) 377– 382[ChemPort] 29. Heberer, T.; Feldmann, D. Contribution of effluents from hospitals and private households to the total loads of diclofenac and carbamazepine in municipal sewage effluents - modeling versus measurements J. Hazard. Mater. 2005, 122 ( 3) 211– 218[CrossRef], [PubMed], [ChemPort] 30. Heidler, J.; Halden, R. U. Mass balance assessment of triclosan removal during conventional sewage treatment Chemosphere 2007, 66 ( 2) 362– 369[CrossRef], [PubMed], [ChemPort] 31. Heidler, J.; Sapkota, A.; Halden, R. U. Partitioning, persistence, and accumulation in digested sludge of the topical antiseptic triclocarban during wastewater treatment Environ. Sci. Technol. 2006, 40 ( 11) 3634– 3639[ACS Full Text ], [PubMed], [ChemPort] 32. Jones, O. A. H.; Voulvoulis, N.; Lester, J. N. The occurrence and removal of selected pharmaceutical compounds in a sewage treatment works utilising activated sludge treatment Environ. Pollut. 2007, 145 ( 3) 738– 744[CrossRef], [PubMed], [ChemPort] 33. Joss, A.; Andersen, H.; Ternes, T.; Richle, P. R.; Siegrist, H. Removal of estrogens in municipal wastewater treatment under aerobic and anaerobic conditions: Consequences for plant optimization Environ. Sci. Technol. 2004, 38 ( 11) 3047– 3055[ACS Full Text ], [PubMed], [ChemPort] 34. Kasprzyk-Hordern, B.; Dinsdale, R. M.; Guwy, A. J. Illicit drugs and pharmaceuticals in the environment - Forensic applications of environmental data. Part 1: Estimation of the usage of drugs in local communities Environ. Pollut. 2009, 157 ( 6) 1773– 1777[CrossRef], [PubMed], [ChemPort] 35. Kosonen, J.; Kronberg, L. The occurrence of antihistamines in sewage waters and in recipient rivers Environ. Sci. Pollut. Res. 2009, 16 ( 5) 555– 564[CrossRef], [PubMed], [ChemPort] 36. Kreuzinger, N.; Clara, M.; Strenn, B.; Kroiss, H. Relevance of the sludge retention time (SRT) as design criteria for wastewater treatment plants for the removal of endocrine disruptors and pharmaceuticals from wastewater Water Sci. Technol. 2004, 50 ( 5) 149– 156[PubMed], [ChemPort] 37. Kummerer, K.; Steger Hartmann, T.; Meyer, M. Biodegradability of the anti-tumour agent ifosfamide and its occurrence in hospital effluents and communal sewage Water Res. 1997, 31 ( 11) 2705– 2710[CrossRef], [ChemPort] 38. Kunnemeyer, J.; Terborg, L.; Meermann, B.; Brauckmann, C.; Scheffer, I. M. A.; Karst, U. Speciation Analysis of Gadolinium Chelates in Hospital Effluents and Wastewater Treatment Plant Sewage by a Novel HILIC/ICP-MS Method Environ. Sci. Technol. 2009, 43 ( 8) 2884– 2890[ACS Full Text ], [PubMed] 39. Kupper, T.; Plagellat, C.; Braendli, R. C.; de Alencastro, L. F.; Grandjean, D.; Tarradellas, J. Fate and removal of polycyclic musks, UV filters and biocides during wastewater treatment Water Res. 2006, 40 ( 14) 2603– 2612[CrossRef], [PubMed], [ChemPort] 40. Langford, K. H.; Thomas, K. V. Determination of pharmaceutical compounds in hospital effluents and their contribution to wastewater treatment works Environ. Int. 2009, 35 ( 5) 766– 770[CrossRef], [PubMed], [ChemPort] 41. Leclercq, M.; Mathieu, O.; Gomez, E.; Casellas, C.; Fenet, H.; Hillaire-Buys, D. Presence and Fate of Carbamazepine, Oxcarbazepine, and Seven of Their Metabolites at Wastewater Treatment Plants Arch. Environ. Contam. Toxicol. 2009, 56 ( 3) 408– 415[CrossRef], [PubMed], [ChemPort] 42. Lenz, K.; Mahnik, S. N.; Weissenbacher, N.; Mader, R. M.; Krenn, P.; Hann, S.; Koellensperger, G.; Uhl, M.; Knasmuller, S.; Ferk, F.; Bursch, W.; Fuerhacker, M. Monitoring, removal and risk assessment of cytostatic drugs in hospital wastewater Water Sci. Technol. 2007, 56 ( 12) 141– 149[CrossRef], [PubMed], [ChemPort] 43. Lindqvist, N.; Tuhkanen, T.; Kronberg, L. Occurrence of acidic pharmaceuticals in raw and treated sewages and in receiving waters Water Res. 2005, 39 ( 11) 2219– 2228[CrossRef], [PubMed], [ChemPort] 44. Lishman, L.; Smyth, S. A.; Sarafin, K.; Kleywegt, S.; Toito, J.; Peart, T.; Lee, B.; Servos, M.; Beland, M.; Seto, P. Occurrence and reductions of pharmaceuticals and personal care products and estrogens by municipal wastewater treatment plants in Ontario, Canada Sci. Total Environ. 2006, 367 ( 2−3) 544– 558[PubMed], [ChemPort] 45. Loganathan, B.; Phillips, M.; Mowery, H.; Jones-Lepp, T. L. Contamination profiles and mass loadings of macrolide antibiotics and illicit drugs from a small urban wastewater treatment plant Chemosphere 2009, 75 ( 1) 70– 77[CrossRef], [PubMed], [ChemPort] 46. Mari, F.; Politi, L.; Biggeri, A.; Accetta, G.; Trignano, C.; Di Padua, M.; Bertol, E. Cocaine and heroin in waste water plants: A 1-year study in the city of Florence, Italy Forensic Sci. Int. 2009, 189 ( 1−3) 88– 92[CrossRef], [PubMed], [ChemPort] 47. Matamoros, V.; Arias, C.; Brix, H.; Bayona, J. M. Preliminary screening of small-scale domestic wastewater treatment systems for removal of pharmaceutical and personal care products Water Res. 2009, 43 ( 1) 55– 62[CrossRef], [PubMed], [ChemPort] 48. Matamoros, V.; Hijosa, M.; Bayona, J. M. Assessment of the pharmaceutical active compounds removal in wastewater treatment systems at enantiomeric level. Ibuprofen and naproxen Chemosphere 2009, 75 ( 2) 200– 205[CrossRef], [PubMed], [ChemPort] 49. Maurer, M.; Escher, B. I.; Richle, P.; Schaffner, C.; Alder, A. C. Elimination of beta-blockers in sewage treatment plants Water Res. 2007, 41 ( 7) 1614– 1622[CrossRef], [PubMed], [ChemPort] 50. McAvoy, D. C.; Schatowitz, B.; Jacob, M.; Hauk, A.; Eckhoff, W. S. Measurement of triclosan in wastewater treatment systems Environ. Toxicol. Chem. 2002, 21 ( 7) 1323– 1329[CrossRef], [PubMed], [ChemPort] 51. Mullot, J. U.; Karolak, S.; Fontova, A.; Huart, B.; Levi, Y. Development and validation of a sensitive and selective method using GC/MS-MS for quantification of 5-fluorouracil in hospital wastewater Anal. Bioanal. Chem. 2009, 394 ( 8) 2203– 2212[CrossRef], [PubMed], [ChemPort] 52. Musolff, A.; Leschik, S.; Mder, M.; Strauch, G.; Reinstorf, F.; Schirmer, M. Temporal and spatial patterns of micropollutants in urban receiving waters Environ. Pollut. 2009, 157 ( 11) 3069– 3077[CrossRef], [PubMed], [ChemPort] 53. Nakada, N.; Tanishima, T.; Shinohara, H.; Kiri, K.; Takada, H. Pharmaceutical chemicals and endocrine disrupters in municipal wastewater in Tokyo and their removal during activated sludge treatment Water Res. 2006, 40 ( 17) 3297– 3303[CrossRef], [PubMed], [ChemPort] 54. Okuda, T.; Yamashita, N.; Tanaka, H.; Matsukawa, H.; Tanabe, K. Development of extraction method of pharmaceuticals and their occurrences found in Japanese wastewater treatment plants Environ. Int. 2009, 35 ( 5) 815– 820[CrossRef], [PubMed], [ChemPort] 55. Ort, C.; Gujer, W. Sampling for representative micropollutant loads in sewer systems Water Sci. Technol. 2006, 54 ( 6−7) 169– 176[PubMed], [ChemPort] 56. Ort, C.; Lawrence, M. G.; Reungoat, J.; Eaglesham, G.; Carter, S.; Keller, J. Determining the fraction of pharmaceutical residues in wastewater originating from a hospital Water Res. 2010, 44 ( 2) 605– 615[CrossRef], [PubMed], [ChemPort] 57. Ort, C.; Schaffner, C.; Giger, W.; Gujer, W. Modeling stochastic load variations in sewer systems Water Sci. Technol. 2005, 52 ( 5) 113– 122[PubMed], [ChemPort] 58. Paxeus, N. Removal of selected non-steroidal anti-inflammatory drugs (NSAIDs), gemfibrozil, carbamazepine, beta-blockers, trimethoprim and triclosan in conventional wastewater treatment plants in five EU countries and their discharge to the aquatic environment Water Sci. Technol. 2004, 50 ( 5) 253– 260[PubMed], [ChemPort] 59. Peng, X. Z.; Wang, Z. D.; Kuang, W. X.; Tan, J. H.; Li, K. A preliminary study on the occurrence and behavior of sulfonamides, ofloxacin and chloramphenicol antimicrobials in wastewaters of two sewage treatment plants in Guangzhou, China Sci. Total Environ. 2006, 371 ( 1−3) 314– 322[PubMed], [ChemPort] 60. Quintana, J. B.; Weiss, S.; Reemtsma, T. Pathways and metabolites of microbial degradation of selected acidic pharmaceuticals and their occurrence in municipal wastewater treated by a membrane bioreactor Water Res. 2005, 39 ( 12) 2654– 2664[CrossRef], [PubMed], [ChemPort] 61. Radjenovic, J.; Petrovic, M.; Barcelo, D. Analysis of pharmaceuticals in wastewater and removal using a membrane bioreactor Anal. Bioanal. Chem. 2007, 387 ( 4) 1365– 1377[CrossRef], [PubMed], [ChemPort] 62. Radjenovic, J.; Petrovic, M.; Barcelo, D. Fate and distribution of pharmaceuticals in wastewater and sewage sludge of the conventional activated sludge (CAS) and advanced membrane bioreactor (MBR) treatment Water Res. 2009, 43 ( 3) 831– 841[CrossRef], [PubMed], [ChemPort] 63. Rodriguez, I.; Quintana, J. B.; Carpinteiro, J.; Carro, A. M.; Lorenzo, R. A.; Cela, R. Determination of acidic drugs in sewage water by gas chromatography-mass spectrometry as tert.-butyldimethylsilyl derivatives J. Chromatogr. A 2003, 985 ( 1−2) 265– 274[CrossRef], [PubMed], [ChemPort] 64. Santos, J. L.; Aparicio, I.; Callejon, M.; Alonso, E. Occurrence of pharmaceutically active compounds during 1-year period in wastewaters from four wastewater treatment plants in Seville (Spain) J. Hazard. Mater. 2009, 164 ( 2−3) 1509– 1516[CrossRef], [PubMed], [ChemPort] 65. Simonich, S. L.; Federle, T. W.; Eckhoff, W. S.; Rottiers, A.; Webb, S.; Sabaliunas, D.; De Wolf, W. Removal of fragrance materials during US and European wastewater treatment Environ. Sci. Technol. 2002, 36 ( 13) 2839– 2847[ACS Full Text ], [PubMed], [ChemPort] 66. Smook, T. M.; Zho, H.; Zytner, R. G. Removal of ibuprofen from wastewater: comparing biodegradation in conventional, membrane bioreactor, and biological nutrient removal treatment systems Water Sci. Technol. 2008, 57 ( 1) 1– 8[CrossRef], [PubMed], [ChemPort] 67. Spongberg, A. L.; Witter, J. D. Pharmaceutical compounds in the wastewater process stream in Northwest Ohio Sci. Total Environ. 2008, 397 ( 1−3) 148– 157[PubMed], [ChemPort] 68. StegerHartmann, T.; Kummerer, K.; Schecker, J. Trace analysis of the antineoplastics ifosfamide and cyclophosphamide in sewage water by two-step solid-phase extraction and gas chromatography mass spectrometry J. Chromatogr. A 1996, 726 ( 1−2) 179– 184[CrossRef], [ChemPort] 69. Stumpf, M.; Ternes, T. A.; Wilken, R. D.; Rodrigues, S. V.; Baumann, W. Polar drug residues in sewage and natural waters in the state of Rio de Janeiro, Brazil Sci. Total Environ. 1999, 225 ( 1−2) 135– 141[CrossRef], [PubMed] 70. Tauxe-Wuersch, A.; De Alencastro, L. F.; Grandjean, D.; Tarradellas, J. Occurrence of several acidic drugs in sewage treatment plants in Switzerland and risk assessment Water Res. 2005, 39 ( 9) 1761– 1772[CrossRef], [PubMed], [ChemPort] 71. Ternes, T. A. Occurrence of drugs in German sewage treatment plants and rivers Water Res. 1998, 32 ( 11) 3245– 3260[CrossRef], [ChemPort] 72. Ternes, T. A.; Bonerz, M.; Herrmann, N.; Teiser, B.; Andersen, H. R. Irrigation of treated wastewater in Braunschweig, Germany: An option to remove pharmaceuticals and musk fragrances Chemosphere 2007, 66 ( 5) 894– 904[CrossRef], [PubMed], [ChemPort] 73. Ternes, T. A.; Hirsch, R. Occurrence and behavior of X-ray contrast media in sewage facilities and the aquatic environment Environ. Sci. Technol. 2000, 34 ( 13) 2741– 2748[ACS Full Text ], [ChemPort] 74. Ternes, T. A.; Stumpf, M.; Mueller, J.; Haberer, K.; Wilken, R. D.; Servos, M. Behavior and occurrence of estrogens in municipal sewage treatment plants - I. Investigations in Germany, Canada and Brazil Sci. Total Environ. 1999, 225 ( 1−2) 81– 90[CrossRef], [PubMed], [ChemPort] 75. Thomas, K. V.; Dye, C.; Schlabach, M.; Langford, K. H. Source to sink tracking of selected human pharmaceuticals from two Oslo city hospitals and a wastewater treatment works J. Environ. Monit. 2007, 9 ( 12) 1410– 1418[CrossRef], [PubMed], [ChemPort] 76. Thompson, A.; Griffin, P.; Stuetz, R.; Cartmell, E. The fate and removal of triclosan during wastewater treatment Water Environ. Res. 2005, 77 ( 1) 63– 67[CrossRef], [PubMed], [ChemPort] 77. van Nuijs, A. L. N.; Pecceu, B.; Theunis, L.; Dubois, N.; Charlier, C.; Jorens, P. G.; Bervoets, L.; Blust, R.; Neels, H.; Covaci, A. Spatial and temporal variations in the occurrence of cocaine and benzoylecgonine in waste- and surface water from Belgium and removal during wastewater treatment Water Res. 2009, 43 ( 5) 1341– 1349[CrossRef], [PubMed], [ChemPort] 78. Vasskog, T.; Berger, U.; Samuelsen, P. J.; Kallenborn, R.; Jensen, E. Selective serotonin reuptake inhibitors in sewage influents and effluents from Tromso, Norway J. Chromatogr. A 2006, 1115 ( 1−2) 187– 195[CrossRef], [PubMed], [ChemPort] 79. Vieno, N.; Tuhkanen, T.; Kronberg, L. Elimination of pharmaceuticals in sewage treatment plants in Finland Water Res. 2007, 41 ( 5) 1001– 1012[CrossRef], [PubMed], [ChemPort] 80. Vieno, N. M.; Tuhkanen, T.; Kronberg, L. Seasonal variation in the occurrence of pharmaceuticals in effluents from a sewage treatment plant and in the recipient water Environ. Sci. Technol. 2005, 39 ( 21) 8220– 8226[ACS Full Text ], [PubMed], [ChemPort] 81. Waltman, E. L.; Venables, B. J.; Waller, W. Z. Triclosan in a North Texas wastewater treatment plant and the influent and effluent of an experimental constructed wetland Environ. Toxicol. Chem. 2006, 25 ( 2) 367– 372[CrossRef], [PubMed], [ChemPort] 82. Watkinson, A. J.; Murby, E. J.; Costanzo, S. D. Removal of antibiotics in conventional and advanced wastewater treatment: Implications for environmental discharge and wastewater recycling Water Res. 2007, 41, 4164– 4176[CrossRef], [PubMed], [ChemPort] 83. Watkinson, A. J.; Murby, E. J.; Kolpin, D. W.; Costanzo, S. D. The occurrence of antibiotics in an urban watershed: From wastewater to drinking water Sci. Total Environ. 2009, 407, 2711– 2723[CrossRef], [PubMed], [ChemPort] 84. Weissbrodt, D.; Kovalova, L.; Ort, C.; Pazhepurackel, V.; Moser, R.; Hollender, J.; Siegrist, H.; McArdell, C. S. Mass flows of X-ray Contrast Media and Cytostatics in Hospital Wastewater Environ. Sci. Technol. 2009, 43 ( 13) 4810– 4817[ACS Full Text ], [PubMed], [ChemPort] 85. Wick, A.; Fink, G.; Joss, A.; Siegrist, H.; Ternes, T. A. Fate of beta blockers and psycho-active drugs in conventional wastewater treatment Water Res. 2009, 43 ( 4) 1060– 1074[CrossRef], [PubMed], [ChemPort] 86. Xu, W. H.; Zhang, G.; Li, X. D.; Zou, S. C.; Li, P.; Hu, Z. H.; Li, J. Occurrence and elimination of antibiotics at four sewage treatment plants in the Pearl River Delta (PRD), South China Water Res. 2007, 41, 4526– 4534[CrossRef], [PubMed], [ChemPort] 87. Yu, C. P.; Chu, K. H. Occurrence of pharmaceuticals and personal care products along the West Prong Little Pigeon River in east Tennessee, USA Chemosphere 2009, 75 ( 10) 1281– 1286[CrossRef], [PubMed], [ChemPort] 88. Yu, J. T.; Bouwer, E. J.; Coelhan, M. Occurrence and biodegradability studies of selected pharmaceuticals and personal care products in sewage effluent Agric. Water Manage. 2006, 86 ( 1−2) 72– 80[CrossRef] 89. Zorita, S.; Martensson, L.; Mathiasson, L. Occurrence and removal of pharmaceuticals in a municipal sewage treatment system in the south of Sweden Sci. Total Environ. 2009, 407 ( 8) 2760– 2770[CrossRef], [PubMed], [ChemPort] 90. Zuccato, E.; Chiabrando, C.; Castiglioni, S.; Bagnati, R.; Fanelli, R. Estimating community drug abuse by wastewater analysis Environ. Health Perspect. 2008, 116 ( 8) 1027– 1032[CrossRef], [PubMed], [ChemPort] 91. Gy, P. M. Sampling - the Foundation-Block of Analysis Mikrochim. Acta 1991, 2 ( 1−6) 457– 466[ChemPort] 92. Ramsey, M. H.; Thompson, M. Uncertainty from sampling, in the context of fitness for purpose Accredit. Qual. Assur. 2007, 12 ( 10) 503– 513[CrossRef], [ChemPort] 93. Ort, C.; Lawrence, M. G.; Reungoat, J.; Mueller, J. F. Sampling for PPCPs in wastewater systems: A comparison of different sampling modes and optimization strategies. Environ. Sci. Technol. in press, doi: 10.1021/es100778d.[ACS Full Text ] 94. ISO. Water quality - Sampling - Part 10: Guidance on sampling of waste waters; ISO 5667-10; ISO: Genve, Switzerland, 1992. 95. ISO. Water quality - Sampling - Part 1: Guidance on the design of sampling programmes; ISO 5667-1; ISO: Genve, Switzerland, 1980. 96. Clesceri, L. S.; Greenberg, A. E.; Eaton, A. D. Standard Methods for the Examination of Water and Wastewater; American Public Health Association: Washington, DC, 1998; Vol. 20, ISBN 0875532357 97. Rieckermann, J.; Neumann, M.; Ort, C.; Huisman, J. L.; Gujer, W. Dispersion coefficients of sewers from tracer experiments Water Sci. Technol. 2005, 52 ( 5) 123– 133[PubMed], [ChemPort] 98. Ort, C.; Hollender, J.; Schaerer, M.; Siegrist, H. R. Model-Based Evaluation of Reduction Strategies for Micropollutants from Wastewater Treatment Plants in Complex River Networks Environ. Sci. Technol. 2009, 43 ( 9) 3214– 3220[ACS Full Text ], [PubMed], [ChemPort] 99. Minkkinen, P. Weighting error - is it significant in process analysis? WCBS3, Third World Conference on Sampling and Blending, 22−25 October, 2007; 2007, 1/2007, 59– 68 100. ISO. Water quality - Sampling - Part 2: Guidance on sampling techniques; ISO 5667-2; ISO: Genve, Switzerland, 1991. 101. Morley, M. C.; Snow, D. D.; Kuppig, V. Emerging chemicals and analytical methods Water Environ. Res. 2005, 77, 561– 658[CrossRef], [ChemPort] 102. Richardson, S. D. Water Analysis: Emerging Contaminants and Current Issues Anal. Chem. 2009, 81 ( 12) 4645– 4677[ACS Full Text ], [PubMed], [ChemPort] 103. Wong, C. S.; MacLeod, S. L. JEM spotlight: recent advances in analysis of pharmaceuticals in the aquatic environment J. Environ. Monit. 2009, 11 ( 5) 923– 936[CrossRef], [PubMed], [ChemPort] 104. Mige, C.; Choubert, J. M.; Ribeiro, L.; Eusbe, M.; Coquery, M. Fate of pharmaceuticals and personal care products in wastewater treatment plants - Conception of a database and first results Environ. Pollut. 2009, 157 ( 5) 1721– 1726[CrossRef], [PubMed], [ChemPort] 105. Kagle, J.; Porter, A. W.; Murdoch, R. W.; Rivera-Cancel, G.; Hay, A. G. Biodegradation of Pharmaceutical and Personal Care Products Adv. Appl. Mircobiol. 2009, 67, 65– 108[PubMed], [ChemPort] 106. Onesios, K. M.; Yu, J. T.; Bouwer, E. J. Biodegradation and removal of pharmaceuticals and personal care products in treatment systems: a review Biodegradation 2009, 20 ( 4) 441– 466[CrossRef], [PubMed], [ChemPort] 107. Macleod, S. L.; McClure, E. L.; Wong, C. S. Laboratory calibration and field deployment of the polar organic chemical integrative sampler for pharmaceuticals and personal care products in wastewater and surface water Environ. Toxicol. Chem. 2007, 26 ( 12) 2517– 2529[CrossRef], [PubMed], [ChemPort] 108. Hoppe, H.; Messmann, S.; Giga, A.; Gruning, H. Options and limits of quantitative and qualitative online-monitoring of industrial discharges into municipal sewage systems Water Sci. Technol. 2009, 60 ( 4) 859– 867[CrossRef], [PubMed], [ChemPort] 109. Ort, C.; Siegrist, H. Assessing wastewater dilution in small rivers with high resolution conductivity probes Water Sci. Technol. 2009, 59 ( 8) 1593– 1601[CrossRef], [PubMed], [ChemPort] 110. Zhang, Z.; Grover, D. P.; Zhou, J. L. Monitoring of Pharmaceutical Residues in Sewage Effluents (Chapter 14). In Handbook of Water Purity and Quality: Monitoring of Pharmaceutical Residues in Sewage Effluents; Ahuja, S., Ed.; IWA: 2009. 111. Bertrand-Krajewski, J. L.; Bardin, J. P.; Mourad, M.; Beranger, Y. Accounting for sensor calibration, data validation, measurement and sampling uncertainties in monitoring urban drainage systems Water Sci. Technol. 2003, 47 ( 2) 95– 102[PubMed], [ChemPort] 112. Gromaire, M. C.; Chebbo, G. Pollutant concentration measurement uncertainties in sewage Houille Blanche-Revue Internationale De L Eau 2001, 6−7) 109– 114[CrossRef] 113. Port, E. Requirements for the in-house control of WWTPs (in German) WAR TH Darmstadt 1994, 75, 353– 361[ChemPort] 114. Thomann, M., Data control of WWTPs with mass balances, experiments and statistical methods (in German). Dissertation, ETH Zrich, No 14824. 2002. 115. Rauch, W.; Brockmann, D.; Peters, I.; Larsen, T. A.; Gujer, W. Combining urine separation with waste design: an analysis using a stochastic model for urine production Water Res. 2003, 37 ( 3) 681– 689[CrossRef], [PubMed], [ChemPort] 116. Ternes, T.; Joss, A. Human Pharmaceuticals, Hormones and Fragrances: The challenge of micropollutants in urban water management; IWA Publishing, 2006; ISBN: 1843390930. 117. de Gruijter, J.; Brus, D.; Bierkens, M.; Knotters, M., Sampling for Natural Resource Monitoring; Springer: New York, 2006. 118. Larrarte, F. Suspended solids within sewers: an experimental study Environ. Fluid Mech. 2008, 8 ( 3) 249– 261[CrossRef] 119. Clark, S. E.; Siu, C. Y. S. Measuring solids concentration in stormwater runoff: Comparison of analytical methods Environ. Sci. Technol. 2008, 42 ( 2) 511– 516[ACS Full Text ], [PubMed], [ChemPort] 120. Deo, R. P.; Halden, R. U. Comment on “The removal of pharmaceuticals, personal care products, endocrine disruptors and illicit drugs during wastewater treatment and its impact on the quality of receiving waters” by Barbara Kasprzyk-Hordern, Richard M. Dinsdale, Alan J. Guwy Water Res. 2010, 44 ( 8) 2685– 2687[CrossRef], [PubMed], [ChemPort] 121. Tan, B. L. L.; Hawker, D. W.; Muller, J. F.; Leusch, F. D. L.; Tremblay, L. A.; Chapman, H. F. Comprehensive study of endocrine disrupting compounds using grab and passive sampling at selected wastewater treatment plants in South East Queensland, Australia Environ. Int. 2007, 33 ( 5) 654– 669[CrossRef], [PubMed], [ChemPort] 122. Gy, P. M. The analytical and economic importance of correctness in sampling Anal. Chim. Acta 1986, 190 ( 1) 13– 23[CrossRef], [ChemPort] 123. Leardi, R. Experimental design in chemistry: A tutorial Anal. Chim. Acta 2009, 652 ( 1−2) 161– 172[CrossRef], [PubMed], [ChemPort] 124. Minkkinen, P. O.; Esbensen, K. H. Grab vs. composite sampling of particulate materials with significant spatial heterogeneity--A simulation study of “correct sampling errors” Anal. Chim. Acta 2009, 653 ( 1) 59– 70[CrossRef], [PubMed], [ChemPort] 125. Paakkunainen, M.; Reinikainen, S. P.; Minkkinen, P. Estimation of the variance of sampling of process analytical and environmental emissions measurements Chemometrics Intell. Lab. Syst. 2007, 88 ( 1) 26– 34[CrossRef], [ChemPort] 126. Petersen, L.; Esbensen, K. H. Representative process sampling for reliable data analysis - a tutorial J. Chemometrics 2005, 19 ( 11−12) 625– 647[CrossRef], [ChemPort] 127. ISO. Accuracy (trueness and precision) of measurement method and results - Part 1: General principles and definitions; ISO 5725-1; ISO: Genve, Switzerland, 1994. 128. Allan, I. J.; Vrana, B.; Greenwood, R.; Mills, G. A.; Roig, B.; Gonzalez, C. A “toolbox” for biological and chemical monitoring requirements for the European Union’s Water Framework Directive Talanta 2006, 69 ( 2) 302– 322[CrossRef], [PubMed], [ChemPort] 129. Hanke, G.; Wollgast, J.; Loos, R.; Jimnez, J. C.; Umlauf, G.; Mariani, G.; Mller, A.; Huber, T.; Christoph, E. H.; Locoro, G.; Zaldvar, J. M.; Boidoglio, G. Comparison of Monitoring Approaches for Selected Priority Pollutants in Surface Water; JRC Scientific and Technical Reports, 2007. 130. U.S. EPA. Load estimation techniques (Chapter 7). In National Management Measures to Control Nonpoint Source Pollution from Agriculture; Washington, DC, 2003. 131. Rossi, L.; Rumley, L.; Ort, C.; Minkkinen, P.; Barry, D. A.; Chvre, N., Sampling-helper: a web-based tool to assess the reliability of sampling strategies in sewer systems and receiving waters. Water Sci. Technol. accepted .
Q-Index Code C1
Q-Index Status Confirmed Code
Institutional Status UQ
Additional Notes Received March 10, 2010. Revised manuscript received June 24, 2010. Accepted July 6, 2010.

Document type: Journal Article
Sub-type: Article (original research)
Collections: Official 2011 Collection
Advanced Water Management Centre Publications
 
Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 164 times in Thomson Reuters Web of Science Article | Citations
Scopus Citation Count Cited 181 times in Scopus Article | Citations
Google Scholar Search Google Scholar
Created: Thu, 12 Aug 2010, 12:21:13 EST by Hong Lee on behalf of Advanced Water Management Centre